Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/1999
11/09/1999US5981541 Substituted heterocycles as anti-tumor agents
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981539 Piperidine compounds as calcium channel blockers
11/09/1999US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists
11/09/1999US5981115 Recording layer comprises a resin an isocyanate compound crosslinked with resin, electron donating coloring agent and an electron accepting coloring developer
11/09/1999CA2167912C Process for the preparation of sufentanil derivatives by carbene addition/aminolysis of 4-piperidone
11/04/1999WO1999055704A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055673A1 Arylphenyl-substituted cyclic keto enols
11/04/1999WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
11/04/1999WO1999048894B1 Novel cephalotaxane derivatives and process for their preparation
11/04/1999CA2329434A1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof
11/02/1999US5977169 Substituted tetronic acids useful for treating HIV and other retroviruses
11/02/1999US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
11/02/1999US5977106 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives
10/1999
10/28/1999WO1999054330A1 2,3-olefinic epothilone derivatives
10/28/1999WO1999054319A1 12,13-modified epothilone derivatives
10/28/1999WO1999054318A1 12,13-cyclopropane epothilone derivatives
10/28/1999WO1999054303A1 Optically active tetrahydrobenzindole derivatives
10/28/1999WO1999053951A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/28/1999WO1999043654A3 Inhibitors of phospholipase enzymes
10/28/1999DE19818732A1 New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides
10/28/1999DE19808261A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols
10/28/1999CA2329413A1 2,3-olefinic epothilone derivatives
10/28/1999CA2329319A1 Optically active tetrahydrobenzindole derivatives
10/28/1999CA2323609A1 12,13-cyclopropane epothilone derivatives
10/27/1999CN1233239A Process for preparing 2-azadihydroxybicyclo [2,2,1] heptane compounds and the L-tartaric acid salt of the compound
10/27/1999CN1045962C Pyridopyridazinone or pyridopyridazine-thione compound, intermediate for preparing it, pharmaceutical composite containing the same and its use
10/27/1999CN1045957C Tricyclic benzazepine, their application and preparation
10/26/1999US5973085 Monomers and composition which can be crosslinked and crosslinked polymers
10/26/1999US5972979 Tricyclic spiro compounds as 5HT1D receptor antagonists
10/26/1999US5972970 Oxazolidinedione derivatives, their production and use
10/26/1999US5972955 Water soluble C-ring analogues of 20(S)-camptothecin
10/26/1999US5972951 Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
10/26/1999US5972935 Psychological disordrs, nervous system disorders, parkinson's disorder
10/26/1999CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/21/1999WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999WO1999052888A1 Butenolide derivatives as anti-cancer agents
10/21/1999WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application
10/21/1999WO1999052871A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element
10/21/1999WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis
10/21/1999WO1999026927A3 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
10/21/1999CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/20/1999EP0950661A1 Substituted tricyclics useful in sPLA2 induced diseases
10/20/1999EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
10/20/1999EP0950054A1 Substituted heterocycles as anti-tumor agents
10/20/1999EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/20/1999EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
10/20/1999CN1232450A 2- and 2,5-substd. phenylketoenols
10/19/1999US5969150 Fluorescent compounds for medical diagnosis, drugs and labels or fungicides and viricides
10/19/1999US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease
10/19/1999US5968954 Exhibit selective binding affinity for 5-hydroxytryptamine receptors
10/19/1999US5968943 Derivatives of camptothecin and methods of treating cancer using these derivatives
10/19/1999US5968937 For treatment and/or prevention of hypertension, cardiac insufficiency, coronary vasospasm, cardiac ischemia, renal vasospasm, liver cirrhosis, congestive heart failure, nephrotic syndrome, brain edema, cerebral ischemia
10/19/1999US5968930 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
10/17/1999CA2269256A1 Substituted tricyclics
10/14/1999WO1999051229A1 Treatment of panic attacks
10/14/1999DE19817517A1 New benzylguanidine derivatives useful for diagnosis or therapy, especially of neuroblastoma
10/14/1999CA2325948A1 Treatment of panic attacks
10/13/1999EP0948499A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
10/12/1999US5965728 Process for the preparation of a salt clavulanic acid
10/12/1999US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999US5965566 High molecular weight polymer-based prodrugs
10/07/1999WO1999050253A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999CA2322203A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
10/06/1999EP0947514A1 Novel phenanethridinium derivatives
10/06/1999EP0947513A1 Tricyclic amine derivatives
10/06/1999EP0946569A2 Cycloaliphatic epoxy compounds
10/06/1999EP0946567A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/06/1999EP0946566A1 Pro-drugs and counterparts of camptothecin, their application as medicines
10/06/1999EP0946564A1 New process for the preparation of morphinans
10/06/1999EP0946556A1 Combinatorial process for preparing hydrofuroquinoline libraries
10/06/1999EP0946542A1 Indane or dihydroindole derivatives
10/06/1999EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
10/06/1999CN1230948A Pyranoindole and carbazole inhibitors of COX-2
10/05/1999US5962499 Acaricidal, antiparasitic, insecticidal and anthelmintic agents
10/05/1999US5962469 Cyclic nitrones
10/05/1999US5962467 Derivatives of swainsonine and their use as therapeutic agents
10/05/1999US5962465 Brain disorders; psychological disorders
10/05/1999US5962462 Spiro-substituted azacycles as modulators of chemokine receptor activity
10/05/1999US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
09/1999
09/30/1999WO1999048894A1 Novel cephalotaxane derivatives and process for their preparation
09/30/1999WO1999048869A1 Aryl phenyl substituted cyclic ketoenols
09/30/1999DE19813354A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols
09/30/1999CA2324895A1 Novel cephalotaxane derivatives and process for their preparation
09/29/1999EP0944633A1 Substituted phenylketoenols and their use as pesticides and herbicides
09/29/1999EP0944386A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/29/1999EP0944385A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING $i(HELICOBACTER PYLORI) INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH
09/29/1999CN1230188A 25-methylene and 24,25-epoxy marcfortines and paraheroquamides
09/28/1999US5959116 Pyridine-2, 3-dicarboximides their preparation and their use for controlling undesired plant growth
09/28/1999US5959110 Substituted tetrahydro-1h-naph(1,2,3-de)isoquinoline compound useful for treating nervous system disorders
09/28/1999US5958970 Tricyclic and tetracyclic pyrones
09/28/1999US5958936 For inducing antiandrogenic activity in warm-blooded animals, including humans
09/28/1999US5958930 Treating cancer, and secondary infections caused by pneumocystis carinii and toxoplasmosis gondii in immunocompromised patients.
09/28/1999US5958903 Cholinesterase inhibitors
09/28/1999US5958792 Combinatorial libraries of substrate-bound cyclic organic compounds
09/22/1999EP0942911A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
09/22/1999EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders